Aurora Cannabis (NYSE:ACB)‘s stock had its “hold” rating reissued by analysts at GMP Securities in a research report issued to clients and investors on Tuesday. They currently have a $9.50 price objective on the stock. GMP Securities’ target price suggests a potential upside of 32.50% from the stock’s current price.
NYSE ACB opened at $7.17 on Tuesday. The firm has a market capitalization of $7.58 billion and a P/E ratio of 39.95. The company has a current ratio of 6.54, a quick ratio of 5.68 and a debt-to-equity ratio of 0.07. Aurora Cannabis has a 12 month low of $4.05 and a 12 month high of $12.52.
Aurora Cannabis (NYSE:ACB) last issued its quarterly earnings results on Monday, November 12th. The company reported $0.09 earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.04) by $0.13. The firm had revenue of $22.71 million during the quarter. Aurora Cannabis had a net margin of 224.33% and a return on equity of 8.57%.
A number of large investors have recently modified their holdings of the stock. QCI Asset Management Inc. NY boosted its stake in Aurora Cannabis by 4.8% during the 4th quarter. QCI Asset Management Inc. NY now owns 86,159 shares of the company’s stock worth $427,000 after purchasing an additional 3,913 shares during the period. Flagship Harbor Advisors LLC acquired a new stake in Aurora Cannabis during the 4th quarter worth $26,000. Trustcore Financial Services LLC acquired a new stake in Aurora Cannabis during the 4th quarter worth $33,000. Farmers & Merchants Trust Co of Chambersburg PA acquired a new stake in Aurora Cannabis during the 4th quarter worth $36,000. Finally, Baldwin Brothers Inc. MA acquired a new stake in Aurora Cannabis during the 4th quarter worth $40,000. Hedge funds and other institutional investors own 1.27% of the company’s stock.
Aurora Cannabis Company Profile
Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.
Recommended Story: Why is the ROA ratio important?
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.